| 1 |
34619854 | [Immune regulatory effect of tacrolimus in patients with severe aplastic anemia and in murine model]. | 2021 Jun 29 |
1 |
| 2 |
34668283 | Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study. | 2021 Dec |
1 |
| 3 |
35126303 | The Alteration of Circulating Lymphocyte Subsets During Tacrolimus Therapy in Neuromyelitis Optica Spectrum Disorder and Its Correlation With Clinical Outcomes. | 2021 |
2 |
| 4 |
32180132 | Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo. | 2020 Dec |
1 |
| 5 |
32499781 | A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis. | 2020 |
1 |
| 6 |
32749395 | Bioinspired β-glucan microcapsules deliver FK506 to lymph nodes for treatment of cardiac allograft acute rejection. | 2020 Oct 7 |
1 |
| 7 |
32817992 | Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF). | 2020 Aug |
2 |
| 8 |
30293884 | Clinical efficacy of tacrolimus for treating myasthenia gravis and its influence on lymphocyte subsets. | 2019 Jan - Feb |
1 |
| 9 |
30472069 | Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients. | 2019 Feb |
3 |
| 10 |
30931336 | Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients. | 2019 |
1 |
| 11 |
28673995 | Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway. | 2017 Jul 18 |
1 |
| 12 |
28747916 | Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. | 2017 |
2 |
| 13 |
25905982 | Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. | 2015 Sep |
1 |
| 14 |
25925687 | Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. | 2015 Dec |
1 |
| 15 |
24342979 | Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. | 2014 Feb 15 |
1 |
| 16 |
23274966 | Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. | 2013 Feb 15 |
1 |
| 17 |
22008665 | The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients. | 2012 Jan 10 |
1 |
| 18 |
21195813 | Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis. | 2011 Apr |
1 |
| 19 |
21227887 | Effects of tacrolimus on IFN-γ signaling in keratinocytes: possible mechanisms by which tacrolimus affects IFN-γ-dependent skin inflammation. | 2011 Jan-Feb |
12 |
| 20 |
19880819 | Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. | 2010 Oct |
1 |
| 21 |
20159692 | [Effect of FK506 on cytokine secretion in whole blood]. | 2010 Feb |
2 |
| 22 |
18262659 | Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. | 2008 Mar |
1 |
| 23 |
17594193 | Tacrolimus in the treatment of idiopathic nephrotic syndrome. | 2007 Jul |
1 |
| 24 |
16641133 | Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes. | 2006 Jul |
2 |
| 25 |
17051976 | Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). | 2006 Jul-Aug |
1 |
| 26 |
15996247 | Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. | 2005 Aug |
1 |
| 27 |
14767008 | In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. | 2004 Mar |
1 |
| 28 |
15115509 | Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. | 2004 May |
1 |
| 29 |
12767900 | Inhibition of interferon-gamma-activated nuclear factor-kappa B by cyclosporin A: A possible mechanism for synergistic induction of apoptosis by interferon-gamma and cyclosporin A in gastric carcinoma cells. | 2003 Jun 13 |
2 |
| 30 |
11407316 | Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). | 2001 Jun |
1 |
| 31 |
11477316 | Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. | 2001 Aug |
3 |
| 32 |
11563819 | Impact of tacrolimus and bone marrow augmentation on intestinal allograft survival and intragraft cytokine expression in rats. | 2001 |
1 |
| 33 |
10789681 | Involvement of FK506-sensitive and insensitive granule exocytosis pathways in perforin-dependent target cell lysis mediated by a CD8+ CTL clone. | 2000 Apr 3 |
2 |
| 34 |
11131636 | A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. | 2000 Sep- Oct |
2 |
| 35 |
11137126 | Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. | 2000 Dec 29 |
2 |
| 36 |
10205001 | Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages. | 1999 Mar |
1 |
| 37 |
10515221 | Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. | 1999 Oct |
1 |
| 38 |
9510155 | Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. | 1998 Mar 15 |
1 |
| 39 |
9190906 | Autocrine and paracrine regulation of human T cell IL-10 production. | 1997 Jun 15 |
1 |
| 40 |
8846199 | Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. | 1995 Sep |
1 |
| 41 |
7519528 | Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. | 1994 Jul |
1 |
| 42 |
7526029 | Inhibitory effect of FK506 on intercellular adhesion molecule-1 (ICAM-1) expression on cultured thyroid cells. | 1994 |
1 |
| 43 |
7507316 | Immunosuppressants: tools to investigate the physiological role of cytokines. | 1993 Nov |
1 |
| 44 |
7509103 | FK506 inhibits phytohemagglutinin-, but not interferon-gamma-, induced HLA-DR antigen expression and accessory cell function on primary cultured human thyroid cells. | 1993 Dec |
1 |
| 45 |
7680613 | Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. | 1993 Mar |
1 |
| 46 |
7683267 | Acute effects of FK506 and cyclosporine A on cultured human proximal tubular cells. | 1993 Apr 1 |
1 |
| 47 |
1371491 | Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. | 1992 Jan |
2 |
| 48 |
1380951 | The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells. | 1992 Jul |
1 |
| 49 |
1717376 | The immunosuppressive macrolides FK-506 and rapamycin. | 1991 Jul |
1 |
| 50 |
2472451 | The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. | 1989 Jul 15 |
1 |